• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[醋酸卤泼尼龙对大鼠的致畸性研究]

[Teratogenicity study on halopredone acetate in rats].

作者信息

Imoto S, Kamada S, Yahata A, Kosaka M, Takeuchi M, Shinpo K, Sudo J, Tanabe T

出版信息

J Toxicol Sci. 1985 Aug;10 Suppl 1:83-103. doi: 10.2131/jts.10.supplementi_83.

DOI:10.2131/jts.10.supplementi_83
PMID:4068064
Abstract

A teratogenicity study of halopredone acetate (THS-201), a synthetic corticosteroid, was carried out using Jcl: Wistar rats. Pregnant rats were treated subcutaneously in doses of 0.1, 0.5, 2.5 and 12.5 mg/kg/day, from day 7 to day 17 of gestation. Two-thirds of pregnant rats were killed on day 20 of gestation to examine the development of fetuses, and remaining rats were allowed to litter naturally in order to investigate the postnatal development of offspring. The results obtained from the present study were as follows. During the gestation and lactation periods, there occurred a decrease in the maternal body weight gain in 2.5 and 12.5 mg/kg groups. No influences of THS-201 administration were observed on gestation, delivery and lactation of dams. No external, visceral and skeletal anomalies attributable to THS-201 were observed in the fetuses. THS-201 administration did not have any influences on viability and development, various functions such as reflex response, learning and reproductive performance of F1 generation, and further on development of F2 generation. Therefore, it was concluded that the non-effect dose of THS-201 for the reproduction of dams and development of F1 generation was 12.5 mg/kg/day.

摘要

使用Jcl: Wistar大鼠对合成皮质类固醇醋酸卤泼尼龙(THS - 201)进行了致畸性研究。妊娠大鼠在妊娠第7天至第17天接受皮下注射,剂量分别为0.1、0.5、2.5和12.5 mg/kg/天。三分之二的妊娠大鼠在妊娠第20天处死,以检查胎儿发育情况,其余大鼠自然产仔,以研究后代的产后发育情况。本研究获得的结果如下。在妊娠和哺乳期,2.5和12.5 mg/kg组的母鼠体重增加有所减少。未观察到给予THS - 201对母鼠的妊娠、分娩和哺乳有影响。在胎儿中未观察到归因于THS - 201的外部、内脏和骨骼异常。给予THS - 201对F1代的活力和发育、各种功能如反射反应、学习和生殖性能以及F2代的进一步发育均无影响。因此,得出结论,THS - 201对母鼠繁殖和F1代发育的无作用剂量为12.5 mg/kg/天。

相似文献

1
[Teratogenicity study on halopredone acetate in rats].[醋酸卤泼尼龙对大鼠的致畸性研究]
J Toxicol Sci. 1985 Aug;10 Suppl 1:83-103. doi: 10.2131/jts.10.supplementi_83.
2
[Peri- and postnatal study on halopredone acetate in rats].[醋酸卤泼尼龙对大鼠的围产期及产后研究]
J Toxicol Sci. 1985 Aug;10 Suppl 1:105-22. doi: 10.2131/jts.10.supplementi_105.
3
[Fertility study on halopredone acetate in rats].[醋酸卤泼尼龙对大鼠的生育力研究]
J Toxicol Sci. 1985 Aug;10 Suppl 1:71-81. doi: 10.2131/jts.10.supplementi_71.
4
[Study on toxicity of halopredone acetate. (III). Chronic toxicity study in rats].[醋酸卤泼尼龙的毒性研究。(III)。大鼠慢性毒性研究]
J Toxicol Sci. 1985 Aug;10 Suppl 1:41-69. doi: 10.2131/jts.10.supplementi_41.
5
[Study on toxicity of halopredone acetate. (II). Subacute toxicity study in rats].[醋酸卤泼尼龙的毒性研究。(二)。大鼠亚急性毒性研究]
J Toxicol Sci. 1985 Aug;10 Suppl 1:11-39. doi: 10.2131/jts.10.supplementi_11.
6
[Study on toxicity of halopredone acetate. (I) Acute toxicity study in mice and rats].醋酸卤泼尼龙的毒性研究。(I)小鼠和大鼠急性毒性研究
J Toxicol Sci. 1985 Aug;10 Suppl 1:1-10. doi: 10.2131/jts.10.supplementi_1.
7
[Reproductive and developmental toxicity study of mofezolac (N-22) (2)--Study by oral administration of N-22 during the period of fetal organogenesis in rats].莫非佐辛(N - 22)的生殖与发育毒性研究(2)——大鼠胎儿器官形成期经口给予N - 22的研究
J Toxicol Sci. 1990 Jun;15 Suppl 2:165-208. doi: 10.2131/jts.15.supplementii_165.
8
[Effects of intravenous administration of ranitidine hydrochloride to the pregnant rat in organogenesis period].[盐酸雷尼替丁静脉注射对器官形成期妊娠大鼠的影响]
J Toxicol Sci. 1984 Jun;9 Suppl 1:29-52. doi: 10.2131/jts.9.supplementi_29.
9
[Teratogenicity study on bromperidol in rats].[溴哌利多对大鼠的致畸性研究]
J Toxicol Sci. 1984 Jun;9 Suppl 1:109-26. doi: 10.2131/jts.9.supplementi_109.
10
Reproductive toxicity studies in rats with rimexolone, a corticoid ophthalmic suspension.
Toxicol Sci. 1999 Oct;51(2):280-8. doi: 10.1093/toxsci/51.2.280.